Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

ZD1839 can cause skin issues like acne and hair changes.

OR2AT4 helps reduce aging and cell damage in human skin cells.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

RXRα is crucial for hair growth and skin cell function.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Analog 23 is a promising compound for prostate cancer treatment.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.